What are the normal values for a hepatic (liver) panel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values for Hepatic (Liver) Panel

The normal reference ranges for liver function tests include ALT <30 U/L for men and <19 U/L for women, AST <40 U/L, alkaline phosphatase <120 U/L, total bilirubin <1.0 mg/dL, and albumin 3.5-5.0 g/dL, according to the most recent guidelines. 1

Standard Components of a Hepatic Panel

A comprehensive hepatic panel typically includes:

  • Alanine aminotransferase (ALT)

    • Men: <30 U/L
    • Women: <19 U/L
    • Note: Traditional upper limits (40 U/L for men, 30 U/L for women) may be too high 2
  • Aspartate aminotransferase (AST)

    • <40 U/L
  • Alkaline phosphatase (ALP)

    • Adults: 40-120 U/L
    • Note: Values <40 U/L are uncommon (0.25% of patients) 3
  • Total bilirubin

    • <1.0 mg/dL
  • Direct (conjugated) bilirubin

    • <0.3 mg/dL
  • Albumin

    • 3.5-5.0 g/dL
  • Gamma-glutamyl transferase (GGT)

    • Men: 8-61 U/L
    • Women: 5-36 U/L

Interpretation Patterns

Pattern Recognition

Liver test abnormalities can be categorized into patterns that help guide diagnosis 1:

  1. Hepatocellular pattern:

    • Predominant elevation of aminotransferases (ALT, AST)
    • AST:ALT ratio <1 suggests viral hepatitis, NAFLD
    • AST:ALT ratio >2 suggests alcoholic liver disease
    • AST:ALT ratio >1 in non-alcoholic disease may suggest cirrhosis 4
  2. Cholestatic pattern:

    • Predominant elevation of ALP and GGT
    • May indicate biliary obstruction or drug-induced liver injury
  3. Mixed pattern:

    • Elevations in both aminotransferases and cholestatic markers

Clinical Significance and Monitoring

  • The extent of liver test abnormality is not necessarily a guide to clinical significance 5
  • Mild elevations (<5× upper limit of normal) are common and may be seen in NAFLD, which affects 20-30% of the general population 1
  • Moderate elevations (5-10× ULN) warrant closer investigation
  • Severe elevations (>10× ULN) may indicate acute hepatitis or drug-induced liver injury 1

Important Considerations

  • ALP may originate from tissues other than the liver, most commonly from bone. Elevated ALP should be confirmed to be of hepatobiliary origin with GGT and/or ALP isoenzyme fractionation 5
  • Laboratory reference ranges may vary between institutions
  • The current upper limits of normal for liver enzymes (particularly ALT) may be too high due to inclusion of patients with subclinical liver disease in reference populations 2
  • Liver enzymes should be monitored every 2-4 weeks until normalization in patients with abnormal values 1

Pitfalls to Avoid

  • Don't assume that normal liver tests exclude significant liver disease - patients with cirrhosis or chronic hepatitis may have normal liver enzymes
  • Don't rely solely on the magnitude of liver test abnormality to determine clinical significance
  • Don't forget that medications can cause liver test abnormalities - a complete medication review should be performed when evaluating abnormal results 1
  • Don't overlook the AST:ALT ratio, which can provide valuable diagnostic clues about the etiology of liver disease 4

References

Guideline

Evaluation and Management of Elevated Liver Function Tests

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.